ChemPartner PharmaTech Co.,Ltd. (SHE:300149)
China · Delayed Price · Currency is CNY 11.15
-0.07 (-0.62%)
At close: Nov 5, 2025
ChemPartner PharmaTech Revenue
ChemPartner PharmaTech had revenue of 283.05M CNY in the quarter ending September 30, 2025, with 11.72% growth. This brings the company's revenue in the last twelve months to 1.07B, up 5.72% year-over-year. In the year 2024, ChemPartner PharmaTech had annual revenue of 970.20M, down -14.77%.
Revenue (ttm)
1.07B
Revenue Growth
+5.72%
P/S Ratio
5.20
Revenue / Employee
589.04K
Employees
1,814
Market Cap
5.55B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 970.20M | -168.16M | -14.77% |
| Dec 31, 2023 | 1.14B | -188.22M | -14.19% |
| Jan 1, 2023 | 1.33B | -364.09M | -21.54% |
| Jan 1, 2022 | 1.69B | 209.09M | 14.11% |
| Dec 31, 2020 | 1.48B | 153.77M | 11.58% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Huadong Medicine | 43.09B |
| WuXi AppTec | 43.07B |
| Yunnan Baiyao Group Co.,Ltd | 40.77B |
| Shanghai Fosun Pharmaceutical (Group) | 39.55B |
| Shenzhen Mindray Bio-Medical Electronics | 33.07B |
| Jiangsu Hengrui Medicine | 30.98B |
| Zhejiang NHU Company | 22.47B |
| Aier Eye Hospital Group | 22.17B |